INTERFERON THERAPY FOR CHRONIC HEPATITIS B and Combination Interferon + Lamivudine
Frontiers | Role of Type I and II Interferons in Colorectal Cancer and Melanoma | Immunology
Peginterferon and Ribavirin for Chronic Hepatitis C | NEJM
Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus | Immunotherapy
Pegylated interferon
Frontiers | Role of Type I and II Interferons in Colorectal Cancer and Melanoma | Immunology
What You Should Know about Peginterferon Alfa-2b for Adjuvant Treatment of Melanoma - The ASCO Post
Pegylated interferon Peginterferon alfa-2b Peginterferon alfa-2a, Dopaminergic Pathways, pegylated Interferon, pegylation, pharmacodynamics png | PNGWing
Pharmaceuticals | Free Full-Text | Antiproliferative Properties of Type I and Type II Interferon | HTML
Mechanisms of action of Interferons. | Download Scientific Diagram
Pegylated interferons α2a and α2b in the treatment of chronic hepatitis C | Nature Reviews Gastroenterology & Hepatology
Human Interferon Alpha-2b: A Therapeutic Protein for Cancer Treatment
Frontiers | When Hepatitis B Virus Meets Interferons | Microbiology
Mechanism of action of interferon and ribavirin in treatment of hepatitis C | Semantic Scholar
Interaction between insulin and the peginterferon alfa 2 signaling... | Download Scientific Diagram
Mechanism of action of ribavirin in the treatment of chronic hepatitis C. - Abstract - Europe PMC
Peginterferon alpha-2a/Peginterferon alpha-2b Pathway (Hepatocyte), Pharmacodynamics
Frontiers | When Hepatitis B Virus Meets Interferons | Microbiology
Off balance: Interferons in COVID-19 lung infections - eBioMedicine
Ribavirin mechanism of action. | Download Scientific Diagram
Interferons α and β in cancer: therapeutic opportunities from new insights | Nature Reviews Drug Discovery
Type I interferons in pancreatic cancer and development of new therapeutic approaches - ScienceDirect
References in Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial - The Lancet
INTERFERON THERAPY FOR CHRONIC HEPATITIS B and Combination Interferon + Lamivudine
